MARKET

BIVIW

BIVIW

Biovie Inc
NASDAQ
0.3059
+0.0346
+12.75%
Closed 13:56 05/15 EDT
OPEN
0.3060
PREV CLOSE
0.2713
HIGH
0.3060
LOW
0.3060
VOLUME
801
TURNOVER
--
52 WEEK HIGH
0.5200
52 WEEK LOW
0.1650
MARKET CAP
--
P/E (TTM)
-0.0596
1D
5D
1M
3M
1Y
5Y
1D
BioVie Q3 FY26 net loss widens to $5.3 million; operating expenses climb to $5.4 million
PUBT · 4d ago
BioVie SUNRISE-PD bezisterim abstract accepted for presentation at 2026 AAN meeting
PUBT · 04/14 12:05
BioVie publishes corporate presentation on bezisterim pipeline catalysts in Parkinson’s, Long Covid
Reuters · 04/01 22:27
BioVie to present SUNRISE-PD bezisterim poster at AD/PD 2026
Reuters · 03/12 12:05
BioVie to Host Live Investor Webinar and Q&A Session with CEO Cuong Do
Reuters · 02/23 13:04
BioVie Inc. Announces Phase 2 and 3 Clinical Trials of Bezisterim for Alzheimer's and Long COVID
Reuters · 02/12 13:01
OPTION THERAPEUTICS INC SAYS THINKEQUITY IS THE UNDERWRITER TO IPO
Reuters · 01/26 11:03
BioVie Inc. unveils new data on bezisterim's potential in Parkinson's and Alzheimer's therapies
Reuters · 01/10 18:53
More

Webull offers Biovie Inc stock information, including NASDAQ: BIVIW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIVIW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIVIW stock methods without spending real money on the virtual paper trading platform.